Stay updated on INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.

Latest updates to the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page
- Check2 days agoChange DetectedNew revision entry: v3.3.4 appears in the page history, and v3.3.3 is removed.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page displays a new Revision: v3.3.3 and the HHS Vulnerability Disclosure footer link has been removed; the prior Revision: v3.3.2 entry was deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedThe old version shows v3.2.0 replaced by v3.3.2 in the page header/footer; no substantive changes to study history, content, or layout are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved a global operating-status notice about government funding and NIH operations from the page; this does not affect trial data, status, or historical records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedThe new screenshot shows a redesigned layout for the Record History page without any changes to the listed trial versions, status, or core data. It appears to be a presentation update rather than a substantive change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check102 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference9%

Stay in the know with updates to INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.